People with a BMI below 27 need further clinical evaluation to determine if a GLP-1 medication is appropriate for them
Part of the GLP-1RA (Liraglutide, Semiglutide) has been verified to be efficacious in the treatment of fatty liver and is employed in the management of T2DM complicated with nonalcoholic fatty liver disease, primarily by ameliorating metabolic dysfunction, insulin resistance, and lipotoxicity of the organs related to its pathogenesis (61), decelerating the fibrosis process and reducing the liver fat content
It generally takes several weeks of consistent use before providers assess how well the medication is working, including changes in appetite, eating habits, and any side effects
She graduated from the University of Manchester and completed her GP training through Whipps Cross Hospital in London
Please contact your healthcare provider if you have any concerns or to discuss any questions that you believe may be relevant to you or your baby
That is exactly what researchers are discovering about how GLP-1 drugs affect blood pressure
